COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1175: Articles 11741-11750  | Next

The glycosylated extracellular domain of MUC1 protects against SARS-CoV-2 infection at the respiratory surface
Chatterjee, M., Huang, L. Z. X., Wang, C., Mykytyn, A. Z., Westendorp, B., Wubbolts, R. W., Bosch, B. J., Haagmans, B., Putten, J. P. M. v., Strijbis, K.
10.1101/2021.10.29.466408 — Posted: 2021-10-29 Discussion: Offsite
Analyzing SARS CoV-2 Patient Data Using Quantum Supervised Machine Learning
Yu, Z.
10.1101/2021.10.26.466019 — Posted: 2021-10-29
Identification of COVID-19 and COPD common key genes and pathways using a protein-protein interaction approach
Thambiraja, T. S., Karuppanan, K., Subramaniam, G., Kumar, S.
10.1101/2021.10.28.466298 — Posted: 2021-10-29
Efficacy of anti-microbial gel vapours against aerosolised coronavirus, bacteria, and fungi
Kalaiselvan, P., Yasir, M., Willcox, M. D. P., Vijay, A. K.
10.1101/2021.10.27.466182 — Posted: 2021-10-29
Camel nanobodies broadly neutralize SARS-CoV-2 variants
Hong, J., Kwon, H. J., Cachau, R., Chen, C. Z., Butay, K. J., Duan, Z., Li, D., Ren, H., Liang, T., Zhu, J., Dandey, V. P., Martin, N. P., Esposito, D., Ortega-Rodriguez, U., Xu, M., Borgnia, M. J., Xie, H., Ho, M.
10.1101/2021.10.27.465996 — Posted: 2021-10-29
Novel pectin from crude polysaccharide of Syzygium aromaticum against SARS-CoV-2 activities by targeting 3CLpro
Jin, C., Feng, B., Pei, R. j., Ding, Y. q., Li, M. x., Chen, X., Du, Z. y., Ding, Y. x., Huang, C. f., Zhang, B., Chen, X. w., Zang, Y., Li, J., Ding, K.
10.1101/2021.10.27.466067 — Posted: 2021-10-29
SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade
Samsudin, F., Raghuvamsi, P., Petruk, G., Puthia, M., Petrlova, J., MacAry, P., Anand, G. S., Schmidtchen, A., Bond, P. J.
10.1101/2021.10.29.466401 — Posted: 2021-10-29 Discussion: Offsite
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
Walters, J. N., Schouest, B., Patel, A., Reuschel, E. L., Schultheis, K., Parzych, E., Maricic, I., Gary, E. N., Purwar, M., Andrade, V. M., Doan, A., Elwood, D., Eblimit, Z., Nguyen, B., Frase, D., Zaidi, F. I., Kulkarni, A., Generotti, A., Kim, J. J., Humeau, L. M., Ramos, S. J., Smith, T. R. F., Weiner, D. B., Broderick, K. E.
10.1101/2021.10.27.466163 — Posted: 2021-10-29
Multi-label topic classification for COVID-19 literature annotation using an ensemble model based on PubMedBERT
Tian, S., Zhang, J.
10.1101/2021.10.26.465946 — Posted: 2021-10-29
Tree-based Correlation Screen and Visualization for Exploring Phenotype-Cell Type Association in Multiple Sample Single-Cell RNA-Sequencing Experiments
Zhang, B., Ji, Z., Ji, H.
10.1101/2021.10.27.466024 — Posted: 2021-10-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).